About Amgen Our treatment areas Healthcare personnel Our medicines News Research Work with us About research Research program Biotechnology by Amgen Amgen has been a pioneer in the development of drugs based on new technology in cell and molecular biology. We have contributed to the development of processes and tools that have built up the global biotechnology industry - and have made it a leading source of medical patient care. Research and Development Amgen's goal has always been to help patients through research, development and production of innovative biological drugs for the treatment of serious diseases. Great scientific progress is being made at Amgen. See and hear the stories from the researchers who make this possible. read more here Research program Amgen has developed a robust and differentiated research program. It includes chemically produced small molecules, medium-sized molecules such as peptides, and large molecules such as antibodies and other types of therapeutic proteins. Amgen's product portfolio and research portfolio also include new treatment methods, such as BiTE® antibody constructs as well as other bispecific molecules, antibody-drug conjugates and immunotherapy. We believe that drug discoveries begin with a deeper understanding of biology. It is our goal to be able to deliver new treatment methods that provide clear benefits and great effects, such as long-term survival in cancer or to prevent severe migraines or severe asthma attacks. read more here Understanding Life. Transforming Medicine. Some of the biggest advances in research are now taking place at Amgen. See and hear the stories from the researchers who make this possible. amgenscience.com Amgen Worldwide Cookie settings Terms of use Privacy Policy Sitemap Amgen © 2020, 2021 Amgen Inc. All rights reserved